InvestorsHub Logo

RandolRocketman

10/27/15 12:46 PM

#8813 RE: BiotechValues #8811

I have to agree.
By the way, now that they have a patented source of bio ink for 3D printing kidney samples, any clue when we might see new contracts selling kidney samples for toxicity testing? I wonder if this will progress to the point of being the default method for kidney function effects testing for Big Pharma?